Email Us Here

[Pangyo Bio & Medical] SK Bioscience's "Domestic No. 1 Vaccine" Effective Against the Omicron Variant

SK Bioscience analyzed the cross-neutralization of booster shots through an extended study of phase 1/2 clinical trials of "SKYCovione GBP510," a synthetic antigen-type COVID-19 vaccine, and confirmed the immune response to the omicron variant.